Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study

202051 citationsJournal Articlegold Open Access

Authors

Chinese Clinical Trial Registry, ID: ChiCTR2000029741 . Registered on 11 February 2020.

Good health and well-being

Published in: Trials

Volume 21, Issue 1, pp. 622-622

Field-Weighted Citation Impact: 1.28